Jan Krásenský

3.0k total citations
87 papers, 2.2k citations indexed

About

Jan Krásenský is a scholar working on Pathology and Forensic Medicine, Rheumatology and Neurology. According to data from OpenAlex, Jan Krásenský has authored 87 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Pathology and Forensic Medicine, 27 papers in Rheumatology and 19 papers in Neurology. Recurrent topics in Jan Krásenský's work include Multiple Sclerosis Research Studies (63 papers), Systemic Lupus Erythematosus Research (22 papers) and Peripheral Neuropathies and Disorders (12 papers). Jan Krásenský is often cited by papers focused on Multiple Sclerosis Research Studies (63 papers), Systemic Lupus Erythematosus Research (22 papers) and Peripheral Neuropathies and Disorders (12 papers). Jan Krásenský collaborates with scholars based in Czechia, United States and Italy. Jan Krásenský's co-authors include Manuela Vaněčková, Dana Horáková, Zdeněk Seidl, Eva Havrdová, Robert Zivadinov, Niels Bergsland, Michaela Týblová, Tomáš Uher, Michael G. Dwyer and Tomáš Kalinčík and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Jan Krásenský

83 papers receiving 2.2k citations

Peers

Countries citing papers authored by Jan Krásenský

Since Specialization

Citations

This map shows the geographic impact of Jan Krásenský's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Krásenský with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Krásenský more than expected).

Fields of papers citing papers by Jan Krásenský

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Krásenský. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Krásenský. The network helps show where Jan Krásenský may publish in the future.

Co-authorship network of co-authors of Jan Krásenský

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Krásenský. A scholar is included among the top collaborators of Jan Krásenský based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Krásenský. Jan Krásenský is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Serum bilirubin concentrations and their association with clinical and radiological outcomes in multiple sclerosis: A large cohort study	Annals of Hepatology	Tomáš Uher, Pavlína Kleinová et al.	0
2	Lipid measures are associated with cognitive functioning in multiple sclerosis patients	Multiple Sclerosis and Related Disorders	Balázs B. Lőrincz, Jan Krásenský et al.	1
3	Lipid and brain volumetric measures in multiple sclerosis patients: findings from a large observational study	Acta Neurologica Belgica	Balázs B. Lőrincz, Michal Vráblík et al.	1
4	CSF Markers of Oxidative Stress Are Associated with Brain Atrophy and Iron Accumulation in a 2-Year Longitudinal Cohort of Early MS	International Journal of Molecular Sciences	Andrea Burgetová, Petr Dušek et al.	3
5	Brain MRI disease burden and sex differences in cognitive performance of patients with multiple sclerosis	Acta Neurologica Belgica	Manuela Vaněčková, Tom Fuchs et al.	7
6	Periventricular gradient of T1 tissue alterations in multiple sclerosis	NeuroImage Clinical	Manuela Vaněčková, Michaela Andělová et al.	14
7	Deep Gray Matter Iron Content in Neuromyelitis Optica and Multiple Sclerosis	BioMed Research International	Andrea Burgetová, Petr Dušek et al.	18
8	Atlas-based tract damage mapping improves 4-year forecast of EDSS in multiple sclerosis	Multiple Sclerosis Journal	Michaela Andělová, Tomáš Uher et al.	1
9	Additive Effect of Spinal Cord Volume, Diffuse and Focal Cord Pathology on Disability in Multiple Sclerosis	Frontiers in Neurology	Michaela Andělová, Tomáš Uher et al.	14
10	Brain Volume Increase in Multiple Sclerosis Patients (P3.362)	Neurology	Michaela Andělová, Jan Krásenský et al.	1
11	Thalamic Iron Differentiates Primary-Progressive and Relapsing-Remitting Multiple Sclerosis	American Journal of Neuroradiology	Andrea Burgetová, Petr Dušek et al.	33
12	Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes	Journal of Neurology Neurosurgery & Psychiatry	Richard W. Browne, B. Weinstock‐Guttman et al.	37
13	Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome	Journal of Neurology	Tomáš Uher, Dana Horáková et al.	41
14	Multiple sclerosis susceptibility loci do not alter clinical and MRI outcomes in clinically isolated syndrome	Genes and Immunity	Tomáš Kalinčík, Charles R.G. Guttmann et al.	17
15	Subcortical and Cortical Gray Matter Atrophy in a Large Sample of Patients with Clinically Isolated Syndrome and Early Relapsing-Remitting Multiple Sclerosis	American Journal of Neuroradiology	Niels Bergsland, Dana Horáková et al.	130
16	Interferon, azathioprine and corticosteroids in multiple sclerosis: 6-year follow-up of the ASA cohort	Clinical Neurology and Neurosurgery	Tomáš Kalinčík, Dana Horáková et al.	16
17	Volumetric MRI Markers and Predictors of Disease Activity in Early Multiple Sclerosis: A Longitudinal Cohort Study	PLoS ONE	Tomáš Kalinčík, Manuela Vaněčková et al.	66
18	Total Elbow Replacement in Patients with Rheumatoid Arthritis	Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca	I. Landor, P Vavřík et al.	4
19	HLA DRB1*1501 is only modestly associated with lesion burden at the first demyelinating event	Journal of Neuroimmunology	Dana Horáková, Robert Zivadinov et al.	14
20	Apolipoprotein E ε4-Positive Multiple Sclerosis Patients Develop More Gray-Matter and Whole-Brain Atrophy: a 15-Year Disease History Model Based on a 4-Year Longitudinal Study	Folia Biologica	Dana Horáková, Michal Kýr et al.	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact